AA	African American
AE	adverse events
B. Fragilis	Bacillus Fragilis
B2M	β2 microglobulin
BRAF	v-raf murine sarcoma viral oncogene homolog B1
CAR	chimeric antigen receptor
CEA	carcinoembryonic antigen
CIMP	CpG island methylator phenotype
CR	complete response
CRC	colorectal cancer
AE	adverse events
B. Fragilis	Bacillus Fragilis
B2M	β2 microglobulin
BRAF	v-raf murine sarcoma viral oncogene homolog B1
CAR	chimeric antigen receptor
CEA	carcinoembryonic antigen
CIMP	CpG island methylator phenotype
CR	complete response
CRC	colorectal cancer
CSF	colony-stimulating factor
CSF1R	colony-stimulating factor 1 receptor
CTLA4	cytotoxic T lymphocyte-associated antigen 4
DCR	disease control rate
DFS	disease-free survival
dMMR	mismatch repair
F. nucleatum	Fusobacterium Nucleatum
HDACi	histone deacetylase inhibitors
HER2	human epidermal growth factor 2
HLA	human leukocyte antigen
HMAs	methyltransferase inhibitors
ICI	immune checkpoint inhibitors
ICOS	inducible T-cell costimulator
IFN-γ	interferon-γ
IgG4	immunoglobulin G4
JAK	Janus kinase
JAK1 and JAK2	Janus kinases 1 and 2
KRAS	Kirsten rat sarcoma 2 viral oncogene homolog